403 related articles for article (PubMed ID: 30054278)
1. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
Zinn PO; Singh SK; Kotrotsou A; Hassan I; Thomas G; Luedi MM; Elakkad A; Elshafeey N; Idris T; Mosley J; Gumin J; Fuller GN; de Groot JF; Baladandayuthapani V; Sulman EP; Kumar AJ; Sawaya R; Lang FF; Piwnica-Worms D; Colen RR
Clin Cancer Res; 2018 Dec; 24(24):6288-6299. PubMed ID: 30054278
[TBL] [Abstract][Full Text] [Related]
2. Radiogenomic analysis of PTEN mutation in glioblastoma using preoperative multi-parametric magnetic resonance imaging.
Li Y; Liang Y; Sun Z; Xu K; Fan X; Li S; Zhang Z; Jiang T; Liu X; Wang Y
Neuroradiology; 2019 Nov; 61(11):1229-1237. PubMed ID: 31218383
[TBL] [Abstract][Full Text] [Related]
3. Radiogenomic-Based Survival Risk Stratification of Tumor Habitat on Gd-T1w MRI Is Associated with Biological Processes in Glioblastoma.
Beig N; Bera K; Prasanna P; Antunes J; Correa R; Singh S; Saeed Bamashmos A; Ismail M; Braman N; Verma R; Hill VB; Statsevych V; Ahluwalia MS; Varadan V; Madabhushi A; Tiwari P
Clin Cancer Res; 2020 Apr; 26(8):1866-1876. PubMed ID: 32079590
[TBL] [Abstract][Full Text] [Related]
4. Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme.
Zinn PO; Mahajan B; Sathyan P; Singh SK; Majumder S; Jolesz FA; Colen RR
PLoS One; 2011; 6(10):e25451. PubMed ID: 21998659
[TBL] [Abstract][Full Text] [Related]
5. Machine learning-based radiomic evaluation of treatment response prediction in glioblastoma.
Patel M; Zhan J; Natarajan K; Flintham R; Davies N; Sanghera P; Grist J; Duddalwar V; Peet A; Sawlani V
Clin Radiol; 2021 Aug; 76(8):628.e17-628.e27. PubMed ID: 33941364
[TBL] [Abstract][Full Text] [Related]
6. Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma.
Beig N; Patel J; Prasanna P; Hill V; Gupta A; Correa R; Bera K; Singh S; Partovi S; Varadan V; Ahluwalia M; Madabhushi A; Tiwari P
Sci Rep; 2018 Jan; 8(1):7. PubMed ID: 29311558
[TBL] [Abstract][Full Text] [Related]
7. Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models.
Kickingereder P; Burth S; Wick A; Götz M; Eidel O; Schlemmer HP; Maier-Hein KH; Wick W; Bendszus M; Radbruch A; Bonekamp D
Radiology; 2016 Sep; 280(3):880-9. PubMed ID: 27326665
[TBL] [Abstract][Full Text] [Related]
8. IDH1 mutation prediction using MR-based radiomics in glioblastoma: comparison between manual and fully automated deep learning-based approach of tumor segmentation.
Choi Y; Nam Y; Lee YS; Kim J; Ahn KJ; Jang J; Shin NY; Kim BS; Jeon SS
Eur J Radiol; 2020 Jul; 128():109031. PubMed ID: 32417712
[TBL] [Abstract][Full Text] [Related]
9. Prediction of survival with multi-scale radiomic analysis in glioblastoma patients.
Chaddad A; Sabri S; Niazi T; Abdulkarim B
Med Biol Eng Comput; 2018 Dec; 56(12):2287-2300. PubMed ID: 29915951
[TBL] [Abstract][Full Text] [Related]
10. Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time.
Liao X; Cai B; Tian B; Luo Y; Song W; Li Y
J Cell Mol Med; 2019 Jun; 23(6):4375-4385. PubMed ID: 31001929
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive O
Hajianfar G; Shiri I; Maleki H; Oveisi N; Haghparast A; Abdollahi H; Oveisi M
World Neurosurg; 2019 Dec; 132():e140-e161. PubMed ID: 31505292
[TBL] [Abstract][Full Text] [Related]
12. Novel Radiomic Features Based on Joint Intensity Matrices for Predicting Glioblastoma Patient Survival Time.
Chaddad A; Daniel P; Desrosiers C; Toews M; Abdulkarim B
IEEE J Biomed Health Inform; 2019 Mar; 23(2):795-804. PubMed ID: 29993848
[TBL] [Abstract][Full Text] [Related]
13. Analysis of heterogeneity of peritumoral T2 hyperintensity in patients with pretreatment glioblastoma: Prognostic value of MRI-based radiomics.
Choi Y; Ahn KJ; Nam Y; Jang J; Shin NY; Choi HS; Jung SL; Kim BS
Eur J Radiol; 2019 Nov; 120():108642. PubMed ID: 31546124
[TBL] [Abstract][Full Text] [Related]
14. MRI Features May Predict Molecular Features of Glioblastoma in
Park CJ; Han K; Kim H; Ahn SS; Choi D; Park YW; Chang JH; Kim SH; Cha S; Lee SK
AJNR Am J Neuroradiol; 2021 Mar; 42(3):448-456. PubMed ID: 33509914
[TBL] [Abstract][Full Text] [Related]
15. Radiogenomics model for overall survival prediction of glioblastoma.
Wijethilake N; Islam M; Ren H
Med Biol Eng Comput; 2020 Aug; 58(8):1767-1777. PubMed ID: 32488372
[TBL] [Abstract][Full Text] [Related]
16. Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma.
Kickingereder P; Neuberger U; Bonekamp D; Piechotta PL; Götz M; Wick A; Sill M; Kratz A; Shinohara RT; Jones DTW; Radbruch A; Muschelli J; Unterberg A; Debus J; Schlemmer HP; Herold-Mende C; Pfister S; von Deimling A; Wick W; Capper D; Maier-Hein KH; Bendszus M
Neuro Oncol; 2018 May; 20(6):848-857. PubMed ID: 29036412
[TBL] [Abstract][Full Text] [Related]
17. Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma.
Li ZC; Bai H; Sun Q; Zhao Y; Lv Y; Zhou J; Liang C; Chen Y; Liang D; Zheng H
Cancer Med; 2018 Dec; 7(12):5999-6009. PubMed ID: 30426720
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.
Gevaert O; Mitchell LA; Achrol AS; Xu J; Echegaray S; Steinberg GK; Cheshier SH; Napel S; Zaharchuk G; Plevritis SK
Radiology; 2014 Oct; 273(1):168-74. PubMed ID: 24827998
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging-based radiomic features for extrapolating infiltration levels of immune cells in lower-grade gliomas.
Zhang X; Liu S; Zhao X; Shi X; Li J; Guo J; Niedermann G; Luo R; Zhang X
Strahlenther Onkol; 2020 Oct; 196(10):913-921. PubMed ID: 32025804
[TBL] [Abstract][Full Text] [Related]
20. Pre-operative MRI radiomics model non-invasively predicts key genomic markers and survival in glioblastoma patients.
Pease M; Gersey ZC; Ak M; Elakkad A; Kotrotsou A; Zenkin S; Elshafeey N; Mamindla P; Kumar VA; Kumar AJ; Colen RR; Zinn PO
J Neurooncol; 2022 Oct; 160(1):253-263. PubMed ID: 36239836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]